Your session is about to expire
← Back to Search
Chemotherapy + Hepatic Arterial Infusion for Colorectal Cancer
Study Summary
This trial is studying a treatment for colorectal cancer that has spread to the liver. The treatment is a combination of chemotherapy drugs and two other drugs, given directly into the arteries around the tumor.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have had a brain tumor before.I have had a heart attack in the last 6 months.My high blood pressure is not under control.I have moderate to severe heart failure.I have moderate to severe issues with blood flow in my limbs.I do not have any serious wounds, ulcers, or unhealed bone fractures.My cancer has not spread outside my liver.My primary tumor is not causing significant bleeding or blocking my intestines.My primary tumor will be removed when my pump is placed.My liver cancer cannot be removed by surgery, as confirmed by specialists.My colorectal cancer has spread to my liver.I can care for myself but may not be able to do active work.I do not have any current infections.I have an irregular heartbeat that needs medication.My seizures are not well controlled despite taking medication.I have not had a stroke or mini-stroke in the last 6 months.I do not have a blockage in my digestive or urinary systems.I haven't had liver surgery, heat treatments, or radiation other than a biopsy.I have never been treated with floxuridine.I have never had treatment directly into my liver's arteries.I am not taking high doses of aspirin or certain pain relievers regularly.My condition has been treated before or not at all.My liver cancer cannot be removed by surgery.I have no other active cancers, except possibly a treatable colorectal tumor.I do not have any bleeding disorders.It has been over 4 weeks since I had radiation therapy to my pelvis.Less than 70% of my liver is affected by cancer.I am fit for major liver surgery.I have unstable chest pain.
- Group 1: Group 2
- Group 2: Group 1
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What are the long-term effects of oxaliplatin treatment?
"While there is some data supporting oxaliplatin's safety, it only received a score of 2 because this is a phase 2 trial and thus there is no clinical evidence yet of the medication's efficacy."
Are individuals over the age of 30 able to participate in this clinical trial?
"This study's inclusion criteria allows for patients aged 18-120 to enroll. There are 183 clinical trials that focus on people under the age of 18 and 2360 for patients over 65."
Are there any patients still being accepted into this program?
"Unfortunately, this clinical trial is not presently open to recruitment. Although, it was updated as recently as February 4th, 2022. There are 1266 other trials actively recruiting patients with colorectal cancer and 1226 for oxaliplatin if you wish to look into other options."
If a patient were interested in enrolling in this clinical trial, how many different hospitals would they have to choose from?
"To make the study more accessible to a larger number of people, it is being run from 5 different locations. They are based in Rockville Centre, Commack and Basking Ridge as well as 2 other undisclosed locations. If you do decide to participate in the trial, please select the site that is most convenient for you to attend in order to minimize travel time and hassle."
Are there other examples of research using oxaliplatin?
"As of right now, 1226 studies are using oxaliplatin. 345 of those ongoing investigations are in Phase 3. Even though a large number of these experiments are based in Guangzhou, Guangdong, there 44731 total locations running trials for this medication."
What is the limit to how many people can join this clinical trial?
"Unfortunately, this clinical trial is no longer looking for participants. The listing was created on May 1st 2007 and edited February 4th 2022. However, there are still many other trials seeking patients with colorectal cancer (1266 active listings) or oxaliplatin (1226 active listings)."
Who meets the ideal candidate criteria for enrolling in this research project?
"This study is enrolling 64 patients with colorectal cancer aged 18 and 120. Most importantly, candidates should meet the following criteria: Must have inoperable liver metastases confirmed by 2-3 hepatobiliary surgeons and the assigned radiologist, Previously treated or untreated disease, Primary tumor may be present at study registration provided it is not obstructing the intestinal lumen or is significantly bleeding, When a margin-negative resection would require resection of all three hepatic veins, both portal veins, or the retrohepatic vena cava, Liver metastases < 70% of the liver parenchyma"
What are the most popular indications for oxaliplatin?
"Oxaliplatin is commonly used to stop the spread of cancer and treat other conditions such as ophthalmia, sympathetic, branch retinal vein occlusion, small cell lung cancer (sclc)."
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger